Daily Stock Analysis, CRL, Charles River Laboratories International Inc, priceseries

Charles River Laboratories International Inc. Daily Stock Analysis
Stock Information
Open
90.87
Close
90.62
High
90.96
Low
90.21
Previous Close
90.39
Daily Price Gain
0.23
YTD High
92.61
YTD High Date
May 9, 2017
YTD Low
75.25
YTD Low Date
Jan 3, 2017
YTD Price Change
14.09
YTD Gain
18.41%
52 Week High
92.61
52 Week High Date
May 9, 2017
52 Week Low
67.20
52 Week Low Date
Nov 3, 2016
52 Week Price Change
5.21
52 Week Gain
6.10%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 6. 2015
64.65
Feb 2. 2015
68.45
18 Trading Days
5.88%
Link
LONG
Mar 4. 2015
76.61
Mar 24. 2015
81.93
14 Trading Days
6.94%
Link
LONG
Mar 31. 2016
75.94
Apr 19. 2016
80.10
13 Trading Days
5.48%
Link
LONG
Jan 31. 2017
80.80
Feb 28. 2017
87.53
19 Trading Days
8.33%
Link
Company Information
Stock Symbol
CRL
Exchange
NYSE
Company URL
www.criver.com
Company Phone
781-222-6000
CEO
James C. Foster
Headquarters
Massachusetts
Business Address
251 BALLARDVALE ST, WILMINGTON, MA 01887
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Laboratories & Research
CIK
0001100682
About

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe to accelerate their research and drug development efforts. It operates through the following business segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Support. The Research Models and Services segment comprises of the production and sale of research models, and also offers services designed to support to clients use of research models in screening drug candidates. The Discovery and Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment offers endotoxin and microbial detection, avian vaccine services and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Description

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.